VICP OTC
Vicapsys Life Sciences, Inc.
1W: -17.2%
1M: -35.0%
3M: -55.5%
YTD: -56.7%
1Y: -63.3%
3Y: +160.0%
5Y: +73.3%
$0.65
+0.14 (+27.45%)
Weekly Expected Move ±47.6%
$0
$0
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$814K
+22.3% ▲
Net Income
-$990K
+16.3% ▲
EPS (Diluted)
$-0.03
+15.8% ▲
EBITDA
-$900K
+11.4% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $31K | $31K | $31K | $0 | $0 |
| Gross Profit | -$31K | -$31K | -$31K | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $102K | $18K | $13K | $15K | $14K |
| SG&A Expenses | $664K | $319K | $631K | $769K | $800K |
| Operating Expenses | $766K | $337K | $645K | $1M | $814K |
| Operating Income | -$766K | -$337K | -$985K | -$1M | -$814K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $135K | $90K |
| Income Before Tax | -$766K | -$237K | -$985K | -$1M | -$990K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$766K | -$237K | -$985K | -$1M | -$990K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.04 | $-0.01 | $-0.03 | $-0.03 | $-0.03 |
| EBITDA | -$734K | -$306K | -$613K | -$1M | -$900K |
| Shares Outstanding | 17M | 18M | 31M | 35M | 34M |